409 related articles for article (PubMed ID: 33921279)
1. Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges.
Combi R; Salsone M; Villa C; Ferini-Strambi L
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921279
[TBL] [Abstract][Full Text] [Related]
2. Dementia with Lewy bodies.
McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
[TBL] [Abstract][Full Text] [Related]
3. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
4. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
[TBL] [Abstract][Full Text] [Related]
6. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy.
Urbizu A; Beyer K
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630630
[TBL] [Abstract][Full Text] [Related]
8. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
Berman SB; Miller-Patterson C
Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
[TBL] [Abstract][Full Text] [Related]
9. Associations Between APOE Variants, Tau and α-Synuclein.
Rodriguez-Vieitez E; Nielsen HM
Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
[TBL] [Abstract][Full Text] [Related]
10. Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
Gonzalez MC; Ashton NJ; Gomes BF; Tovar-Rios DA; Blanc F; Karikari TK; Mollenhauer B; Pilotto A; Lemstra A; Paquet C; Abdelnour C; Kramberger MG; Bonanni L; Vandenberghe R; Hye A; Blennow K; Zetterberg H; Aarsland D;
JAMA Neurol; 2022 Jan; 79(1):32-37. PubMed ID: 34807233
[TBL] [Abstract][Full Text] [Related]
11. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
13. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.
Walker L; Stefanis L; Attems J
J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
15. Increased albumin CSF/serum ratio in dementia with Lewy bodies.
Llorens F; Schmitz M; Gloeckner SF; Kaerst L; Hermann P; Schmidt C; Varges D; Zerr I
J Neurol Sci; 2015 Nov; 358(1-2):398-403. PubMed ID: 26476775
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.
Treglia G; Cason E
J Neuroimaging; 2012 Apr; 22(2):111-7. PubMed ID: 21091814
[TBL] [Abstract][Full Text] [Related]
17. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
[TBL] [Abstract][Full Text] [Related]
18. Imaging in Dementia With Lewy Bodies: An Overview.
Watson R; Colloby SJ
J Geriatr Psychiatry Neurol; 2016 Sep; 29(5):254-60. PubMed ID: 27502300
[TBL] [Abstract][Full Text] [Related]
19. Dementia with Lewy bodies.
Weisman D; McKeith I
Semin Neurol; 2007 Feb; 27(1):42-7. PubMed ID: 17226740
[TBL] [Abstract][Full Text] [Related]
20. Delirium and dementia with Lewy bodies: distinct diagnoses or part of the same spectrum?
Gore RL; Vardy ER; O'Brien JT
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):50-9. PubMed ID: 24860139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
